Suppr超能文献

近年来我们对 HLA-G 生物学认识的进展:来自广泛人类疾病的启示。

Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases.

机构信息

Laboratory of Oncology, Istituto Giannina Gaslini, 16147 Genoa, Italy.

Department of Experimental and Diagnostic Medicine, Section of Microbiology, University of Ferrara, 44121 Ferrara, Italy.

出版信息

J Immunol Res. 2016;2016:4326495. doi: 10.1155/2016/4326495. Epub 2016 Aug 29.

Abstract

HLA-G is a HLA-class Ib molecule with potent immunomodulatory activities, which is expressed in physiological conditions, where modulation of the immune response is required to avoid allograft recognition (i.e., maternal-fetal interface or transplanted patients). However, HLA-G can be expressed de novo at high levels in several pathological conditions, including solid and hematological tumors and during microbial or viral infections, leading to the impairment of the immune response against tumor cells or pathogens, respectively. On the other hand, the loss of HLA-G mediated control of the immune responses may lead to the onset of autoimmune/inflammatory diseases, caused by an uncontrolled activation of the immune effector cells. Here, we have reviewed novel findings on HLA-G functions in different physiological and pathological settings, which have been published in the last two years. These studies further confirmed the important role of this molecule in the modulation of the immune system.

摘要

HLA-G 是一种 HLA 类 Ib 分子,具有强大的免疫调节活性,在需要调节免疫反应以避免同种异体识别的生理条件下表达(即母体-胎儿界面或移植患者)。然而,HLA-G 可以在几种病理条件下高水平新表达,包括实体瘤和血液系统肿瘤以及微生物或病毒感染期间,导致分别针对肿瘤细胞或病原体的免疫反应受损。另一方面,HLA-G 介导的对免疫反应的控制丧失可能导致自身免疫/炎症性疾病的发生,这是由免疫效应细胞的失控激活引起的。在这里,我们回顾了过去两年中在不同生理和病理环境中 HLA-G 功能的新发现。这些研究进一步证实了该分子在免疫系统调节中的重要作用。

相似文献

1
Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases.
J Immunol Res. 2016;2016:4326495. doi: 10.1155/2016/4326495. Epub 2016 Aug 29.
2
HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease.
Front Immunol. 2022 Jan 27;13:796054. doi: 10.3389/fimmu.2022.796054. eCollection 2022.
3
The emerging role of soluble HLA-G in the control of chemotaxis.
Cytokine Growth Factor Rev. 2014 Jun;25(3):327-35. doi: 10.1016/j.cytogfr.2014.04.004. Epub 2014 May 13.
4
The immunosuppressive molecule HLA-G and its clinical implications.
Crit Rev Clin Lab Sci. 2012 May-Jun;49(3):63-84. doi: 10.3109/10408363.2012.677947. Epub 2012 Apr 26.
6
HLA-G Genotype/Expression/Disease Association Studies: Success, Hurdles, and Perspectives.
Front Immunol. 2020 Jul 8;11:1178. doi: 10.3389/fimmu.2020.01178. eCollection 2020.
7
[HLA-G: from feto-maternal tolerance to organ acceptance].
Bull Acad Natl Med. 2014 Apr-May;198(4-5):801-11; discussion 812.
9
Soluble HLA-G: Are they clinically relevant?
Semin Cancer Biol. 2007 Dec;17(6):469-79. doi: 10.1016/j.semcancer.2007.07.004. Epub 2007 Jul 31.
10
Non-classical MHC-I human leukocyte antigen (HLA-G) in hepatotropic viral infections and in hepatocellular carcinoma.
Hum Immunol. 2014 Dec;75(12):1225-31. doi: 10.1016/j.humimm.2014.09.019. Epub 2014 Oct 12.

引用本文的文献

3
Pathways and molecules for overcoming immunotolerance in metastatic gastrointestinal tumors.
Front Immunol. 2024 Apr 5;15:1359914. doi: 10.3389/fimmu.2024.1359914. eCollection 2024.
5
The Molecular Mechanisms of HLA-G Regulatory Function on Immune Cells during Early Pregnancy.
Biomolecules. 2023 Aug 3;13(8):1213. doi: 10.3390/biom13081213.
6
Association of the HLA-G rs66554220 variant with non-segmental vitiligo and its clinical features in Northwestern Mexico population.
Postepy Dermatol Alergol. 2023 Apr;40(2):246-252. doi: 10.5114/ada.2023.127642. Epub 2023 May 31.
7
Human leukocyte antigen and tumor immunotherapy (Review).
Int J Oncol. 2023 Jun;62(6). doi: 10.3892/ijo.2023.5516. Epub 2023 Apr 28.
8
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis.
Front Immunol. 2022 Oct 12;13:1007647. doi: 10.3389/fimmu.2022.1007647. eCollection 2022.
9
HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine.
Genes Dis. 2021 Jun 30;9(5):1220-1233. doi: 10.1016/j.gendis.2021.06.004. eCollection 2022 Sep.

本文引用的文献

1
A distant trophoblast-specific enhancer controls HLA-G expression at the maternal-fetal interface.
Proc Natl Acad Sci U S A. 2016 May 10;113(19):5364-9. doi: 10.1073/pnas.1602886113. Epub 2016 Apr 13.
3
HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients.
Future Microbiol. 2016;11(3):363-73. doi: 10.2217/fmb.15.143. Epub 2016 Mar 2.
5
Association of HLA-G 3' untranslated region variants with type 1 diabetes mellitus.
Hum Immunol. 2016 Apr;77(4):358-64. doi: 10.1016/j.humimm.2016.02.001. Epub 2016 Feb 13.
7
Elevation of HLA-G-expressing DC-10 cells in patients with gastric cancer.
Hum Immunol. 2016 Sep;77(9):800-4. doi: 10.1016/j.humimm.2016.01.003. Epub 2016 Jan 8.
8
An investigation into the association between HLA-G 14 bp insertion/deletion polymorphism and multiple sclerosis susceptibility.
J Neuroimmunol. 2016 Jan 15;290:115-8. doi: 10.1016/j.jneuroim.2015.11.019. Epub 2015 Nov 27.
9
HLA-G impairs host immune response and predicts poor prognosis in pancreatic cancer.
Am J Transl Res. 2015 Oct 15;7(10):2036-44. eCollection 2015.
10
Pregnancy and breastfeeding: a new theory for sHLA-G in breast cancer patients?
Immunol Res. 2016 Apr;64(2):636-9. doi: 10.1007/s12026-015-8764-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验